Eli Lilly Dealt Another Setback as Lung Cancer Drug Flunks Phase III Test – biolegacy

Eli Lilly Dealt Another Setback as Lung Cancer Drug Flunks Phase III Test

Post author:Sam
Post published:October 9, 2017
Post category:BioPharma

October 10, 2017By Alex Keown, BioSpace.com Breaking…
Source: BioSpace